Andrew G. Shuman, MD, FACS is an Assistant Professor in the Department of Otolaryngology - Head and Neck Surgery at the University of Michigan. He is also the Chief of the ENT Section of the Surgery Service at the VA Ann Arbor Health System. He serves as Chief of the Clinical Ethics Service in the Center for Bioethics and Social Sciences in Medicine (CBSSM).
Dr. Shuman completed fellowships in head and neck surgical oncology at Memorial Sloan-Kettering Cancer Center, and in medical ethics at Weill Medical College of Cornell University. He completed his residency in the Department of Otolaryngology - Head and Neck Surgery at the University of Michigan. He is a graduate of the University of Michigan Medical School, and also graduated from the University of Michigan's College of Literature, Science and the Arts.
Areas of Interest
Dr. Shuman is internationally recognized as a thought leader in ethical issues arising within the field of otolaryngology and surgical oncology. His greatest impact involves his work in defining the conceptual dimensions of “surgical ethics,” an emerging focus in the broader field of bioethics, and being able to apply his perspective as a practicing surgeon and clinical ethicist to normative and empirical bioethics research. He received extramural research funding for his work, and has a portfolio of publications in leading journals in the fields of ethics, oncology and otolaryngology. In addition, he has acted as PI on several projects focused on cancer treatment decision-making and precision oncology, tailored to directly inform both the clinical practice and legal regulation of these ethically contentious and clinically complex disciplines. As part of his clinical ethics work on medication access and drug shortages, his efforts evolved into an empiric research interest to improve how institutions communicate regarding these dilemmas as PI on a statewide grant, which then evolved into national efforts to manage access to experimental agents.
In a new paper, researchers and ethicists urge policymakers to view immortal cells differently from other biospecimens as new rules go into effect.
Medical School or Training
- University of Michigan Health System, 2006
- University of Michigan Health System, Otolaryngology-Head and Neck Surgery, MI, 2011
- Head and Neck Surgery, Memorial Sloan Kettering Cancer Center, 2013